Welcome to our dedicated page for EASTMAN CHEMICAL CO SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EASTMAN CHEMICAL CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EASTMAN CHEMICAL CO's regulatory disclosures and financial reporting.
Eastman Chemical (NYSE:EMN) filed a Form 8-K announcing the appointment of Damon Audia to its Board of Directors effective June 27 2025. Audia will serve until the 2026 Annual Meeting and join the Audit, Finance, and Environmental, Safety & Sustainability committees. Compensation will follow the standard non-employee director package disclosed in the 2025 proxy. The company confirmed no related-party transactions or family relationships. A press release detailing the appointment was furnished as Exhibit 99.1. No other material changes were reported.